Saham Olema Pharmaceuticals jatuh 41% berikutan data ujian Roche
- OlehInvesting.com-
Investing.com -- Saham Olema Pharmaceuticals (NASDAQ:OLMA) jatuh 41% pada hari Isnin berikutan keputusan mengecewakan daripada...
Akhir | Tinggi | Rendah | |||||
|---|---|---|---|---|---|---|---|
| 138.05 | 139.65 | 136.90 | -4.65 | -3.26% | 1.69M | ||
| 65.28 | 65.28 | 62.92 | -1.14 | -1.72% | 3.24M | ||
| 63.88 | 63.94 | 60.10 | -1.12 | -1.72% | 2.25M | ||
| 71.26 | 71.98 | 68.76 | +1.14 | +1.63% | 989.84K | ||
| 529.60 | 530.40 | 521.00 | -0.20 | -0.04% | 450.06K | ||
| 828.00 | 828.00 | 805.40 | +3.20 | +0.39% | 75.31K | ||
| 125.30 | 125.30 | 121.32 | +2.04 | +1.66% | 3.99M | ||
| 80.05 | 80.05 | 78.72 | -0.19 | -0.24% | 4.12M | ||
| 127.95 | 128.50 | 125.60 | +0.85 | +0.67% | 1.18M | ||
| 332.40 | 332.40 | 315.60 | -8.80 | -2.58% | 2.27M | ||
| 498.70 | 500.20 | 485.80 | -5.50 | -1.09% | 193.29K | ||
| 724.50 | 724.50 | 706.50 | +6.50 | +0.91% | 109.45K | ||
| 567.40 | 569.20 | 559.60 | -5.60 | -0.98% | 102.31K | ||
| 138.55 | 139.05 | 135.75 | -3.20 | -2.26% | 948.65K | ||
| 812.00 | 822.20 | 789.40 | -7.80 | -0.95% | 167.86K | ||
| 169.90 | 171.30 | 168.40 | -3.00 | -1.74% | 175.58K | ||
| 29.62 | 29.62 | 28.97 | -0.22 | -0.74% | 7.72M | ||
| 2,856.00 | 2,888.00 | 2,828.00 | -24.00 | -0.83% | 26.61K | ||
| 62.70 | 62.78 | 61.16 | -0.10 | -0.16% | 915.86K | ||
| 44.18 | 44.64 | 42.10 | -1.11 | -2.45% | 1.49M |
Investing.com -- Saham Olema Pharmaceuticals (NASDAQ:OLMA) jatuh 41% pada hari Isnin berikutan keputusan mengecewakan daripada...
Investing.com -- Roche Holding (SIX:ROG) mengumumkan pada hari Isnin bahawa kombinasi ubat eksperimen untuk rawatan kanser...
Investing.com -- Carlyle dan CVC telah bersetuju untuk berkongsi yuran prestasi dengan UBS sebagai pertukaran untuk bank itu...
Tiada Laporan Pendapatan telah dijadualkan